Position in ENTA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,121,502
+$1,554,432 QoQ
Shares Held
282,682
+39.1% QoQ
Ownership
0.971%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 10%
None 8%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. ENTA ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ENTA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,121,502 | 282,682 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,567,070 | 203,252 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,337,151 | 211,614 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,232,712 | 270,068 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,098,957 | 277,640 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,558,306 | 282,302 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,708,357 | 297,106 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,014,604 | 194,460 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,673,932 | 129,062 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,304,407 | 189,256 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,689,685 | 179,563 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,197,728 | 196,753 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,532,456 | 445,442 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $21,784,580 | 538,689 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $25,286,688 | 543,566 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $26,447,369 | 509,878 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $24,755,722 | 523,709 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $42,246,753 | 593,520 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $44,997,967 | 601,738 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $34,703,297 | 610,866 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $28,377,119 | 644,788 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $28,975,302 | 587,496 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $28,258,404 | 671,221 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $32,046,595 | 700,013 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $35,992,435 | 716,838 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $36,798,319 | 715,503 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||